Syndax Pharmaceuticals Inc
SNDX· Nasdaq
SNDXSyndax Pharmaceuticals Inc
Filed Mar 8, 2018 · 10-K · 67 days after period end · 0001564590-18-004911
| Metric | Q4 2017 | Q4 2016 | Q4 2015 |
|---|---|---|---|
| Revenue | $1.19M | $305.00K | — |
| Net Income | -$19.10M | -$10.82M | -$5.26M |
| EPS Diluted | -$0.80 | -$0.59 | -$105.57 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Syndax Pharmaceuticals Inc · CIK 1395937 · Engraved from SEC EDGAR
ended Dec 31, 2017 · filed Mar 8, 2018 · 67 d after period end
